Toboroz
A Prospective, Multicenter, Randomized Controlled Trial Investigating the Impact of Fasting Duration on Postoperative Rebleeding Following Esophageal Variceal Ligation.
NCT07774143· The First Affiliated Hospital of Zhengzhou University· Forrás
Contact: Xizeng Zhu
Toboroz
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke
NCT07509645· 3. fázis· Capital Medical University· Forrás
Contact: Yifeng Liu
Még nem toboroz
A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis
NCT07432854· 2/3. fázis· Dermavon Holdings Limited· Forrás
Contact: KunPeng Bian
Toboroz
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms
NCT07228312· Johnson & Johnson Medical (Shanghai) Ltd.· Forrás
Contact: Yuanyuan Gu
Fut, nem toboroz
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2
NCT07263776· 3. fázis· Capital Medical University· Forrás
Toboroz
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NCT07139314· Capital Medical University· Forrás
Contact: Yifeng Liu
Fut, nem toboroz
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NCT07139301· Capital Medical University· Forrás
Még nem toboroz
A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults
NCT07083739· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Chao Li, Bachelor
Még nem toboroz
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
NCT06926647· Beijing 302 Hospital· Forrás
Contact: Yuzhuo Wu
Toboroz
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
NCT06900920· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Chao Li, Bachelor
Fut, nem toboroz
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
NCT06616532· 3. fázis· Biotheus Inc.· Forrás
Toboroz
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
NCT06548971· 3. fázis· Capital Medical University· Forrás
Contact: Jun Sun
Toboroz
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT)
NCT06559241· 3. fázis· Capital Medical University· Forrás
Contact: Changming Wen
Toboroz
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
NCT06413654· 2/3. fázis· Shanghai Jiaolian Drug Research and Development Co., Ltd· Forrás
Contact: Changming Wen
Toboroz
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
NCT06390306· Peking University People's Hospital· Forrás
Contact: Lijuan Duan
Fut, nem toboroz
A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001)
NCT06238843· 3. fázis· Innovent Biologics (Suzhou) Co. Ltd.· Forrás
Fut, nem toboroz
SIM0718 Treatment of Asthma Clinical Study
NCT06488755· 3. fázis· Simcere Pharmaceutical Co., Ltd· Forrás
Fut, nem toboroz
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
NCT06419621· 3. fázis· Biotheus Inc.· Forrás
Toboroz
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
NCT07169656· The First Affiliated Hospital of Zhengzhou University· Forrás
Contact: Xizeng Zhu
Fut, nem toboroz
Evolve China PMCF Study
NCT06368622· Stryker Neurovascular· Forrás
Toboroz
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
NCT06112704· 2. fázis· Hansoh BioMedical R&D Company· Forrás
Contact: Yun Sun
Még nem toboroz
A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer
NCT05990127· 3. fázis· Akeso· Forrás
Contact: Zhifang Yao, M.D.
Fut, nem toboroz
Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)
NCT06073821· 3. fázis· BeOne Medicines· Forrás
Toboroz
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
NCT05696626· 3. fázis· LeonaBio· Forrás
Contact: Hao Zhang
Fut, nem toboroz
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
NCT05899608· 3. fázis· Summit Therapeutics· Forrás
Fut, nem toboroz
A Study of Telitacicept for IgA Nephropathy (TELIGAN)
NCT05799287· 3. fázis· RemeGen Co., Ltd.· Forrás
Fut, nem toboroz
SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis
NCT06047964· B. Braun Medical International Trading Company Ltd.· Forrás
Fut, nem toboroz
A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer
NCT05652894· 3. fázis· Taizhou Hanzhong biomedical co. LTD· Forrás
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
NCT06295679· Amgen· Forrás
Fut, nem toboroz
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT05479994· 2. fázis· BeiGene· Forrás
Fut, nem toboroz
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer
NCT05365178· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Toboroz
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
NCT05294731· 1/2. fázis· BeOne Medicines· Forrás
Contact: BeOne Medicines
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
NCT05346224· 3. fázis· Shanghai Henlius Biotech· Forrás
Még nem toboroz
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Forrás
Contact: Gang Li
Toboroz
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
NCT04937283· Shanghai Pulmonary Hospital, Shanghai, China· Forrás
Contact: Xinwei Dong